KALV vs BIIB: Which Stock is Better?
Side-by-side comparison of Kalvista Pharmaceuticals Inc and Biogen Inc in 2026
KALV
Kalvista Pharmaceuticals Inc
$20.48
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | KALV | BIIB | Winner |
|---|---|---|---|
| Market Cap | $1.00B | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | 0.3% | -0.1% | KALV |
| Gross Margin | 25.7% | 78.9% | BIIB |
Analyze KALV
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KALV or BIIB a better investment?
Comparing KALV and BIIB: Kalvista Pharmaceuticals Inc has a market cap of $1.00B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KALV and BIIB?
KALV (Kalvista Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KALV or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KALV or BIIB?
KALV has higher revenue growth at 0.3% vs -0.1% for BIIB.
Which company is more profitable: KALV or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 25.7% for KALV.
Which is the larger company: KALV or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $1.00B for KALV.
Should I buy KALV or BIIB in 2026?
Both KALV and BIIB have investment merit. KALV trades at $20.48 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KALV and BIIB stock?
Key differences: Market Cap ($1.00B vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.3% vs -0.1%), Gross Margin (25.7% vs 78.9%).